GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: compound B [WO2022002018A1] | LY-3499446
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: LY3499446 is a direct inhibitor of oncogenic KRAS mutant G12C that was developed for anticancer potential [1].
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| LY3499446 inhibits downstream KRASG12C-mediated ERK phosphorylation in NCI-H358 cells with an IC50 of 8.9 nM [2]. | 
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||